GlycosBio is seen as one of Evolva's biggest rivals. GlycosBio is headquartered in Houston, Texas, and was founded in 2007. Like Evolva, GlycosBio also works within the Biotechnology sector. GlycosBio generates 25% the revenue of Evolva.
Amyris is seen as one of Evolva's top competitors. Amyris was founded in 2003, and its headquarters is in Emeryville, California. Amyris operates in the Biotechnology industry. Amyris has 495 more employees than Evolva.
August 4, 2020
Feed and Grain
August 5, 2020
Evolva's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 11.7B. Over the last two quarters, Evolva's revenue has decreased by 0%. Specifically, in Q4 2019's revenue was $11.9M; in Q3 2019, it was $11.9M.
These are all the companies that Evolva has acquired. Evolva's latest acquisition was Allylix Inc. in Nov 2014. Allylix develops terpene products for the fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.
No recent investments found related to Evolva